FeesSafety
Pluang+

Chemours sued for securities fraud after stock drops 18.63% over Opteon demand claims.

Market News
27 Oct 2026, 12:46 WIB
PRNewsWire
View Source
Bearish
Chemours sued for securities fraud after stock drops 18.63% over Opteon demand claims.

Chemours faces a class action lawsuit alleging securities fraud after its stock fell 18.63% following disclosures that it misrepresented demand for its Opteon refrigeration products. The company had claimed sustained growth driven by regulatory adoption of the AIM Act, but later revealed customers were oversupplied, leading to reduced sales and lowered earnings guidance. The lawsuit, filed in Delaware, accuses Chemours of misleading investors about product demand, and investors have until December 7, 2026, to join the case.

The Chemours class action lawsuit is the subject, providing context for readers. For those tracking Basic Materials, here is Pluang's market snapshot: out of 83 priced US stocks, 34 rose and 42 fell today. Notable movers include WDFC at USD 216.09 (+1.59%), SOLS at USD 60.36 (+1.58%), and CRS at USD 293.61 (+1.43%). This data is as of Oct 27, 2026 13:41 WIB.

More News

CareCloud appoints Mitchell Brie as Chief Compliance Officer to boost its healthcare compliance services.

CareCloud appoints Mitchell Brie as Chief Compliance Officer to boost its healthcare compliance services.

CareCloud has named Mitchell Brie as Chief Compliance Officer to lead its growing healthcare compliance business. Brie, founder of Empower Healthcare & Compliance Partners (acquired by CareCloud), will oversee corporate compliance and continue as Pre...

Market News
Bullish
57 minutes ago
Defense contractors must review CUI access before licensing Microsoft 365 Copilot in GCC High cloud.

Defense contractors must review CUI access before licensing Microsoft 365 Copilot in GCC High cloud.

eSoftware Associates advises defense contractors to carefully map controlled unclassified information (CUI) access permissions before licensing Microsoft 365 Copilot in the GCC High cloud environment. Moving to GCC High does not automatically grant c...

Market News
Neutral
1 hour ago
Man Group discloses 5.64% stake in Vesuvius plc amid offer involving RHI Magnestia N.V.

Man Group discloses 5.64% stake in Vesuvius plc amid offer involving RHI Magnestia N.V.

Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...

Neutral
1 hour ago
Nautilus reports Q3 2026 results with $0.2M revenue, $15.6M net loss, and advances in proteome analysis tech.

Nautilus reports Q3 2026 results with $0.2M revenue, $15.6M net loss, and advances in proteome analysis tech.

Nautilus Biotechnology announced its Q3 2026 financial results, reporting $0.2 million in revenue mainly from grants and early access services, and a net loss of $15.6 million. The company highlighted progress in its proteome analysis platform, inclu...

Company Fundamentals
Bullish
2 hours ago
Eviden launches ASTRA-LAS, a new AI-powered tactical decision-support tool for naval operations.

Eviden launches ASTRA-LAS, a new AI-powered tactical decision-support tool for naval operations.

Eviden, part of Atos Group, has introduced ASTRA-LAS, a tactical decision-support solution designed to aid naval officers in complex maritime environments. The system uses operational data and AI to enhance situational awareness, reduce cognitive loa...

Others
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App